MURUGAN
RAMALINGAM
INVESTIGADOR/A DISTINGUIDO/A
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Cantón, ChinaPublications en collaboration avec des chercheurs de First Affiliated Hospital of Guangzhou University of Chinese Medicine (1)
2024
-
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives
Biomedicine and Pharmacotherapy, Vol. 179